Biothelis
La société BIOTHELIS développe et commercialise le dispositif médical ENDOMARK H1A permettant de prédire la survenue d'une détresse respiratoire grave chez les patients admis en soins intensifs. Applicable aux pneumonies à COVID-19, il permet d'optimiser la prise en charge des patients et améliorer le pronostic.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Biothelis
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Biothelis
1 distinct titles indexed · top 1 shown.
- 1fondateur
Sign up to unlock all 1 contacts at Biothelis
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Biothelis
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.